Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Xinhua Chemical Co.,Ltd (603867.SS)
Jiande, SD, CN
Zhejiang Xinhua Chemical Co.,Ltd manufactures and trades in various chemicals and chemical raw material in China and internationally. It offers fatty amines, organic solvents, flavors, hydrogen peroxide organic amine series, inorganic chemicals, and custom chemicals. The company also offers aroma chemicals, such as turpentine oil derivatives, sandal series, ester series, and others flame retardants; and peroxide series, synthetic ammonia, and other fine chemicals. Zhejiang Xinhua Chemical Co.,Ltd was formerly known as Jiande City Xinhua Chemical Co.,Ltd and changed its name to Zhejiang Xinhua Chemical Co.,Ltd in June 2008. The company was founded in 1967 and is based in Jiande, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.64% | -11.72% | +10.74% | -0.24% | +37.29% | +49.45% | +59.90% | +11.58% | +117.04% | +110.30% | +110.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-0.8% Q1'26: +7.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+18.0% ★ Q1'26: +8.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.5% Q1'26: -15.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+13.0% ★ Q1'26: +11.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.8% ★ Q1'26: +9.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-2.7% ★ Q1'26: +5.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.52× ★ Q1'26: 1.59× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
2.32B
est: 1.98B (+17.5%)
|
2.55B
est: 2.04B (+25.5%)
|
2.68B
est: 2.80B (-4.3%)
|
2.60B
est: 2.72B (-4.4%)
|
2.97B
est: 3.13B (-5.1%)
|
2.94B
est: 3.35B (-12.2%)
|
3.69B
3.69B – 3.69B
+10.1% YoY
|
4.07B
4.07B – 4.07B
+10.4% YoY
|
| EBITDA |
346.12M
est: 322.07M (+7.5%)
|
335.29M
est: 331.77M (+1.1%)
|
523.33M
est: 456.98M (+14.5%)
|
464.04M
est: 442.96M (+4.8%)
|
474.03M
est: 696.94M (-32.0%)
|
550.73M
est: 747.11M (-26.3%)
|
822.24M
822.24M – 822.24M
+10.1% YoY
|
907.86M
907.30M – 908.41M
+10.4% YoY
|
| EBIT |
261.81M
est: 247.81M (+5.6%)
|
250.13M
est: 255.27M (-2.0%)
|
426.13M
est: 351.61M (+21.2%)
|
364.51M
est: 340.83M (+6.9%)
|
345.12M
est: 435.35M (-20.7%)
|
381.45M
est: 466.68M (-18.3%)
|
513.62M
513.62M – 513.62M
+10.1% YoY
|
567.09M
566.75M – 567.44M
+10.4% YoY
|
| Net Income |
205.55M
est: 232.73M (-11.7%)
|
196.82M
est: 208.86M (-5.8%)
|
329.23M
est: 335.04M (-1.7%)
|
252.62M
est: 279.28M (-9.5%)
|
226.91M
est: 335.93M (-32.5%)
|
260.44M
est: 269.88M (-3.5%)
|
343.48M
343.48M – 343.48M
+27.3% YoY
|
409.53M
409.53M – 409.53M
+19.2% YoY
|
| SGA |
133.11M
est: 52.10M (+155.5%)
|
126.16M
est: 53.67M (+135.1%)
|
142.90M
est: 73.92M (+93.3%)
|
157.83M
est: 71.65M (+120.3%)
|
166.25M
est: 153.72M (+8.1%)
|
77.72M
est: 164.79M (-52.8%)
|
181.36M
181.36M – 181.36M
+10.1% YoY
|
200.24M
200.12M – 200.37M
+10.4% YoY
|
| EPS |
1.13
est: 1.20 (-5.8%)
|
1.08
est: 1.08 (+0.3%)
|
1.79
est: 1.73 (+3.6%)
|
1.36
est: 1.44 (-5.6%)
|
1.24
est: 1.78 (-30.3%)
|
1.38
est: 1.43 (-3.5%)
|
1.82
1.82 – 1.82
+27.3% YoY
|
2.17
2.17 – 2.17
+19.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 223.4K | 0.39% |
| 2 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 106.4K | 0.29% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 114.4K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chaofan Yang | Accounting Supervisor | — | — |
| Jianhong Hu | Board Secretary & Director | — | male |
| Lihong Xu | Chief Engineer | — | male |
| Sibin Ying | GM & Chairman | — | male |
| Weiming Wang | Director & Deputy GM | — | male |
| Xinli Zhang | Deputy General Manager | — | male |
| Yiqin Hong | Chief Financial Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603867.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
